Unknown

Dataset Information

0

Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.


ABSTRACT:

Background and objectives

Hypophosphatemia is common in the first year after kidney transplantation, but its clinical implications are unclear. We investigated the relationship between the severity of post-transplant hypophosphatemia and mortality or death-censored graft failure in a large cohort of renal transplant recipients with long-term follow-up.

Design, setting, participants, & measurements

We performed a longitudinal cohort study in 957 renal transplant recipients who were transplanted between 1993 and 2008 at a single center. We used a large real-life dataset containing 28,178 phosphate measurements (median of 27; first to third quartiles, 23-34) serial measurements per patient) and selected the lowest intraindividual phosphate level during the first year after transplantation. The primary outcomes were all-cause mortality, cardiovascular mortality, and death-censored graft failure.

Results

The median (interquartile range) intraindividual lowest phosphate level was 1.58 (1.30-1.95) mg/dl, and it was reached at 33 (21-51) days post-transplant. eGFR was the main correlate of the lowest serum phosphate level (model R2 =0.32). During 9 (5-12) years of follow-up, 181 (19%) patients developed graft failure, and 295 (35%) patients died, of which 94 (32%) deaths were due to cardiovascular disease. In multivariable Cox regression analysis, more severe hypophosphatemia was associated with a lower risk of death-censored graft failure (fully adjusted hazard ratio, 0.61; 95% confidence interval, 0.43 to 0.88 per 1 mg/dl lower serum phosphate) and cardiovascular mortality (fully adjusted hazard ratio, 0.37; 95% confidence interval, 0.22 to 0.62) but not noncardiovascular mortality (fully adjusted hazard ratio, 1.33; 95% confidence interval, 0.9 to 1.96) or all-cause mortality (fully adjusted hazard ratio, 1.15; 95% confidence interval, 0.81 to 1.61).

Conclusions

Post-transplant hypophosphatemia develops early after transplantation. These data connect post-transplant hypophosphatemia with favorable long-term graft and patient outcomes.

SUBMITTER: van Londen M 

PROVIDER: S-EPMC5544514 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.

van Londen Marco M   Aarts Brigitte M BM   Deetman Petronella E PE   van der Weijden Jessica J   Eisenga Michele F MF   Navis Gerjan G   Bakker Stephan J L SJL   de Borst Martin H MH  

Clinical journal of the American Society of Nephrology : CJASN 20170525 8


<h4>Background and objectives</h4>Hypophosphatemia is common in the first year after kidney transplantation, but its clinical implications are unclear. We investigated the relationship between the severity of post-transplant hypophosphatemia and mortality or death-censored graft failure in a large cohort of renal transplant recipients with long-term follow-up.<h4>Design, setting, participants, & measurements</h4>We performed a longitudinal cohort study in 957 renal transplant recipients who were  ...[more]

Similar Datasets

| S-EPMC7246187 | biostudies-literature
| S-EPMC4991956 | biostudies-literature
2023-10-24 | PXD042188 | Pride
| S-EPMC7790214 | biostudies-literature
| S-EPMC8488867 | biostudies-literature
| S-EPMC5383385 | biostudies-literature
| S-EPMC7719962 | biostudies-literature
| S-EPMC8649960 | biostudies-literature
| S-EPMC5844930 | biostudies-literature
| S-EPMC4877062 | biostudies-literature